| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5883228 | Clinical Lymphoma Myeloma and Leukemia | 2013 | 6 Pages |
Abstract
Combining lenalidomide plus melphalan without prednisone is associated with substantial hematologic toxicity that precludes cyclical administration of adequate drug doses.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Darrell J. White, Nizar J. Bahlis, Deb C. Marcellus, Andrew Belch, A. Keith Stewart, Christine Chen, Michael J. Kovacs, David A. Macdonald, Donna E. Reece, Tony Reiman, Erica Harnett, Ralph M. Meyer, Judy-Anne W. Chapman, Stephen Couban,